Mederacke, Ingmar <br/><br/>
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jul 2011 
 - 1343-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2010.139824  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Arthritis, Psoriatic--drug therapy<br/>Drug Therapy, Combination<br/>Etanercept<br/>Hepatitis B, Chronic--complications<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Latent Tuberculosis--complications<br/>Male<br/>Polyethylene Glycols--therapeutic use<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use